We found a reduced expression of FcRL5 on CD11c+ B cells from MuSK-MG subjects which may suggest that these cells are able to secrete more antibodies compared to FcRL5+ atypical B cells (34). This evidence concerns the gene FCRL5 and myasthenia gravis.